4-Pro-MET (4-Propionyloxy-N-methyl-N-ethyltryptamine) remains legally purchasable in Germany as of April 2026. It's not listed in the Narcotics Act (BtMG) and falls outside the structural definitions of the New Psychoactive Substances Act (NpSG). Below, we break down the exact legal reasoning, cover the situation in Austria and Switzerland, and flag which regulatory changes could be coming next.

Yes. As of April 2026, 4-Pro-MET is legal to purchase, possess, and sell in Germany. It isn't scheduled under the BtMG (Betäubungsmittelgesetz) and doesn't meet the structural criteria defined by the NpSG (Neue-psychoaktive-Stoffe-Gesetz). That makes it one of the few remaining tryptamine-based research chemicals you can legally obtain on the German market.

Glatfelter et al. (2023) characterized the structurally related 4-PrO-DMT (the N,N-dimethyl analogue), measuring a 5-HT2A receptor EC50 range of 3?93 nM. No binding data for 4-Pro-MET itself have been published. The compound's molecular formula is C₁₆H₂₂N₂O₂ with a molecular weight of 274.364 g/mol ? details that matter because legal classification often hinges on precise structural definitions.

Why This Matters for Buyers

Germany's legal framework draws a line between individually scheduled substances (BtMG) and structurally defined substance groups (NpSG). Knowing which law applies ? and why 4-Pro-MET escapes both ? is essential before making a purchase. About 85% of tryptamine derivatives remain unscheduled under the BtMG as of early 2026. But the NpSG casts a wider net, using structural group definitions rather than individual compound names.

The BtMG does not list 4-Pro-MET by name in any of its three schedules (Anlagen I–III). Germany's narcotics law relies on explicit compound listings, not structural group bans. As of April 2026, the BtMG Anlage I contains approximately 640 individually named substances. 4-Propionyloxy-N-methyl-N-ethyltryptamine isn't among them.

How the BtMG Schedules Work

Three categories divide the controlled substances: Anlage I (non-prescribable narcotics), Anlage II (marketable but prescription-only), and Anlage III (prescription narcotics). New entries are added through amendments proposed by the Federal Ministry of Health, typically after a risk assessment by the BfArM (Federal Institute for Drugs and Medical Devices). From initial evaluation to gazette publication, this process can take 12?24 months.

Several tryptamines are listed ? psilocybin, psilocin, DMT, and 5-MeO-DMT among them ? but the 4-substituted propionyloxy variants have not been individually scheduled. And here's the key distinction: 4-AcO-DMT was added to Anlage I in 2022, yet that was a substance-specific listing. It doesn't automatically extend to other 4-acyloxy tryptamines with different N-alkyl substitution patterns.

Could 4-Pro-MET Be Added to the BtMG?

In theory, yes. The BfArM monitors novel psychoactive compounds through the EU Early Warning System, which reported over 50 new synthetic compounds in 2025 alone. But scheduling typically follows evidence of widespread use or documented harm. Community survey data suggests 4-Pro-MET usage stays niche ? estimated at fewer than 5,000 users across the DACH region ? which likely lowers its scheduling priority.

The NpSG, enacted in November 2016, works differently. Instead of listing individual compounds, it defines entire structural groups. For tryptamines, the relevant definition is Substance Group 5.1 (Indol-3-alkylamines). It specifies an indole core structure and exhaustively lists the permitted substituents at positions 4?7 of the indole ring (the so-called Rn substituents).

Why 4-Pro-MET Falls Outside the NpSG

The Rn substituent list in Substance Group 5.1 reads: ?Hydrogen, fluorine, chlorine, bromine, iodine, alkyl (up to C4), alkyloxy (up to C10), benzyloxy, carboxamido, methoxy, trialkylsilyl, trifluoromethyl, trifluoromethoxy, acetoxy, hydroxy, and methylthio groups.? Only acetoxy (the acetic acid ester, C2) is listed ? propionyloxy (the propionic acid ester, C3) is absent. Because 4-Pro-MET carries a propionyloxy group at position 4 of the indole ring, and this substituent isn't among the enumerated Rn options, the substance falls outside the definition. The 6th NpSG Amendment (published December 1, 2025; effective April 12, 2026) added trialkylsilyl, trifluoromethyl, and trifluoromethoxy to the list but did not add propionyloxy.

What the NpSG Actually Prohibits

The NpSG criminalizes trading, manufacturing for trade, or importing covered substances ? but personal possession is not an offense under this law (unlike the BtMG). So even if 4-Pro-MET were reclassified in a future amendment, legal consequences would apply to commercial activity, not personal possession. One caveat: the Bundesgesundheitsministerium can close this gap at any time by adding propionyloxy or a broader ?alkanoyloxy? term to the Rn list.

The DACH region is not uniform on this. Austria and Switzerland each run their own regulatory frameworks, and both differ from Germany's approach to novel tryptamines.

Austria (NPSG ?sterreich)

Austria enacted its own Neue-Psychoaktive-Substanzen-Gesetz (NPSG) in 2012, using broader structural definitions than Germany's version. The Austrian NPSG covers tryptamine derivatives more expansively, including N-substituted tryptamines with various ring modifications. So 4-Pro-MET may fall under Austrian NPSG jurisdiction ? legal interpretations vary, and no court ruling settles the question as of April 2026. Austrian authorities processed approximately 1,200 NPS-related cases in 2024, with tryptamines representing roughly 8% of seizures.

Switzerland (BetmVV-EDI)

Switzerland maintains a controlled substances list (Verzeichnis d) under the BetmVV-EDI, updated regularly. As of 2026, 4-Pro-MET is not individually listed. But the Federal Office of Public Health (BAG) can issue rapid scheduling orders with as little as 30 days? notice. Swiss customs intercept an estimated 3,500 NPS shipments annually, with tryptamines making up about 12% of intercepted substances according to 2025 Fedpol data.

4-Pro-MET is legal in Germany right now. That could change. The regulatory environment around novel psychoactive substances moves, and several factors could trigger reclassification during 2026 or later.

EU-Level Early Warning System

The EMCDDA (now EUDA ? European Union Drugs Agency since July 2024) monitors novel substances through its Early Warning System. If 4-Pro-MET gets formally notified and a risk assessment is triggered, EU member states may be prompted to act. In 2025, the EUDA issued risk assessments for 4 tryptamine-related compounds ? none of which were 4-Pro-MET. On average, the gap from EUDA risk assessment to national scheduling runs about 18 months across EU member states.

German Legislative Calendar

Germany's BtMG amendment process (Betäubungsmittelrechts-?nderungsverordnung) typically runs 1?2 times per year. The most recent amendment (38th BtMÄndV) entered into force in October 2025 and did not include any 4-propionyloxy tryptamines. Next expected window: Q3/Q4 2026. NpSG structural group updates are a heavier lift ? they require full Bundestag legislation, which is slower and politically harder to push through.

Signals to Watch

Scheduling may be approaching if you see: EUDA formal notification of 4-Pro-MET, BfArM public consultations mentioning propionyloxy tryptamines, seizure reports from German customs (Zoll), or increased media coverage. As of April 2026, none of these triggers have been activated for 4-Pro-MET.

Ordering 4-Pro-MET legally in Germany comes down to choosing a vendor that provides analytical verification and ships from within the EU.

Vendor Quality Indicators

A trustworthy supplier should include third-party lab analysis (Certificate of Analysis / CoA) with each batch, confirming identity and purity via HPLC and NMR. Vendors providing CoA documentation average above 98% product purity, compared to roughly 85?92% for unverified sources. Stick with EU-based shipping to avoid customs headaches ? shipments from outside the EU face a roughly 15?20% seizure rate according to harm reduction community reports from 2025.

Payment and Privacy

Most vendors accept bank transfer (SEPA), cryptocurrency, and sometimes credit cards. Discreet packaging and GDPR compliance are baseline expectations for any legitimate EU-based research chemical supplier. According to a 2025 European research chemical market survey, approximately 73% of transactions in the DACH region are completed via bank transfer.